Fabrication, Characterization and Toxicity Evaluation Chemically Cross Linked Polymeric Material: A Proof of Concept

Author:

Panda Subhranshu,Suryawanshi Meghraj

Abstract

Background: Natural mucilage is a highly beneficial biodegradable polymeric material. Natural mucilage is non-toxic, biodegradable and easily available. Aim: The current study is required to determine the properties of a basil seed mucilage-based polymeric network and its toxicity. Method: By using potassium persulfate (KPS) as an initiator, microwave-assisted synthesis, a green approach was used to produce a graft copolymer of a polymeric blend of Basil seed mucilage (BSM) and acrylamide (AM). Variable amounts of AM and KPS were used to optimize the best grade based on the highest percentage of grafting efficiency, and the results were investigated using intrinsic viscosity measurement, Fourier Transformation infrared spectroscopy (FTIR), DSC, H-NMR spectra, and X-ray diffraction. The degree of swelling is determined by the concentration of mucilage, monomer, and the density of crosslinking in the polymeric network.  Result: The microwave irradiation process with potassium persulfate as the redox initiator is a visible, green, and cost-effective method. The BSM-4 batch showed 464% grafting and 107.23 % grafting efficiency. FTIR, DSC, H-NMR, and XRD analysis showed results about completing the grafting process and changes in functional groups. The BSM-4 batch proved that the basil seed mucilage polymeric network is safe for oral drug delivery of BCS class II and IV drugs. The findings of the toxicity study indicate that the developed polymeric network is safe and non-toxic, and it may eventually prove to be a superior option for many established and cutting-edge drug delivery methods when administering drugs orally. Conclusion: In conclusion, the Basil seed mucilage-based polymeric network will encourage long-term delivery of any BCS Class II or IV drug, and acute toxicity testing proved that the mucilage-based network is secure for oral drug delivery.

Publisher

BSP Books Private Limited

Subject

Pharmacology (medical),Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,Pharmacy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3